Allscripts Healthcare Solutions Upgraded to “Neutral” by B. Riley (MDRX)
Allscripts Healthcare Solutions (NASDAQ:MDRX) was upgraded by research analysts at B. Riley from a “sell” rating to a “neutral” rating in a report released on Tuesday, TheFlyOnTheWall.com reports. The firm currently has a $16.00 price target on the stock, up from their previous price target of $13.00. B. Riley’s target price would suggest a potential downside of 6.87% from the company’s current price.
A number of other firms have also recently commented on MDRX. Analysts at Morgan Stanley reiterated an “overweight” rating on shares of Allscripts Healthcare Solutions in a research note to investors on Wednesday, January 15th. They now have a $20.00 price target on the stock, up previously from $17.00. Separately, analysts at JPMorgan Chase & Co. initiated coverage on shares of Allscripts Healthcare Solutions in a research note to investors on Monday, December 9th. They set an “overweight” rating and a $18.00 price target on the stock. Finally, analysts at Deutsche Bank initiated coverage on shares of Allscripts Healthcare Solutions in a research note to investors on Wednesday, November 20th. They set a “buy” rating and a $19.00 price target on the stock. Ten analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. The company has an average rating of “Hold” and an average price target of $17.09.
Shares of Allscripts Healthcare Solutions (NASDAQ:MDRX) traded up 2.94% during mid-day trading on Tuesday, hitting $17.18. 2,824,867 shares of the company’s stock traded hands. Allscripts Healthcare Solutions has a 1-year low of $10.24 and a 1-year high of $17.25. The stock has a 50-day moving average of $15.33 and a 200-day moving average of $15.. The company’s market cap is $3.061 billion.
Allscripts Healthcare Solutions (NASDAQ:MDRX) last issued its quarterly earnings data on Thursday, November 7th. The company reported $0.05 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.08 by $0.03. The company had revenue of $334.00 million for the quarter, compared to the consensus estimate of $355.30 million. During the same quarter in the prior year, the company posted $0.23 earnings per share. The company’s quarterly revenue was down 7.5% on a year-over-year basis. Analysts expect that Allscripts Healthcare Solutions will post $0.27 EPS for the current fiscal year.
Allscripts Healthcare Solutions, Inc (NASDAQ:MDRX) is a provider of clinical, financial, connectivity and information solutions and related professional services to hospitals, physicians and post-acute organizations.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.